Taken together, these data demonstrate that GATA2 has high frequent genomic amplification correlating with its increased expression, and GATA2 alterations including amplification and overexpression are profoundly associated with PCa progression to metastasis and hold potential prognostic value in PCa risk prediction. Here, GATA2 is linked to posterior cortical atrophy.